Long-Term Follow-up of Untreated Stage T1a Prostate Cancer

Authors:

Abstract
Stage T1a prostate cancer is defined as incidental adenocarcinoma detected at the time of the transurethral resection of the prostate (TURP), involving 5% or less of the resected prostatic tissue (1). It is estimated that 6.5% of men undergoing TURP will have stage T1a adenocarcinoma of the prostate (2). The biologic potential of stage T1a adenocarcinoma is uncertain (2). Some studies (3,4) have suggested that a significant proportion of patients (16%–26%) with stage T1a carcinoma will have clinically aggressive disease. However, our knowledge is limited with regard to the long-term outcome for untreated patients with stage T1a cancer. A recent study (5) indicated that 8% of men with untreated, clinically occult, and incidental cancer have metastatic progression with up to 15 years follow-up.

This publication has 8 references indexed in Scilit: